Australian Pharmacist

Thom, 37, a regular patient of the pharmacy, presents their venlafaxine repeat for dispensing. You know this has been prescribed for PTSD and ask how they have been going with their treatment. They disclose that their symptoms have been difficult to manage over the last few weeks and that they don’t feel like their medication has been working as well. Thom explains that a friend mentioned MDMA could be used for PTSD, and they’re now considering taking it to help them feel better.

With better treatments than ever, why don’t patients with respiratory conditions show better outcomes as well?

Ziqi is a regular at your pharmacy. She has popped in today to purchase a salbutamol pressurised metered dose inhaler (pMDI). You notice on her dispensing history that this will be her third in the last 4 weeks and she is overdue to have her repeat for her budesonide dry powder inhaler (DPI) filled.

Turning informal advice into a structured consultation service: pharmacy-based travel health services take flight.

So far, community pharmacists have administered enough COVID-19 vaccine doses to fully vaccinate more than 1 million people. But that's just a number – here's what it really looks like.

A small study has investigated community pharmacist attitudes to the over-the-counter (OTC) supply of sildenafil in New Zealand, finding it has enhanced their primary...